Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children
- 31 July 2006
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 36 (3) , 215-221
- https://doi.org/10.1016/j.jcv.2006.03.010
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Impact of a 9-Valent Pneumococcal Conjugate Vaccine on the Public Health Burden of Pneumonia in HIV-Infected and -Uninfected ChildrenClinical Infectious Diseases, 2005
- Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trialThe Lancet, 2005
- A role for Streptococcus pneumoniae in virus-associated pneumoniaNature Medicine, 2004
- A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV InfectionNew England Journal of Medicine, 2003
- Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumoniaThe Pediatric Infectious Disease Journal, 2002
- An update on respiratory syncytial virus epidemiology: a developed country perspectiveRespiratory Medicine, 2002
- Rates of hospitalization for respiratory syncytial virus infection among children in MedicaidThe Journal of Pediatrics, 2000
- Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk InfantsPediatrics, 1998
- Risk factors for respiratory syncytial virus associated apnoeaEuropean Journal of Pediatrics, 1998
- Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young ChildrenNew England Journal of Medicine, 1993